WELL Health Technologies Corp. (TSX: WELL)
4.770
-0.020 (-0.42%)
Jul 19, 2024, 4:00 PM EDT
WELL Health Technologies Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Operating Revenue | 838.19 | - | - | - | - | - | Upgrade
|
Revenue | 838.19 | 776.05 | 569.14 | 302.32 | 50.24 | 32.81 | Upgrade
|
Revenue Growth (YoY) | 36.95% | 36.36% | 88.25% | 501.76% | 53.12% | 262.50% | Upgrade
|
Cost of Revenue | 449.87 | 403.79 | 265.85 | 148.63 | 29.03 | 21.82 | Upgrade
|
Gross Profit | 388.32 | 372.27 | 303.29 | 153.7 | 21.22 | 10.99 | Upgrade
|
Selling, General & Admin | 280.53 | 270.39 | 215 | 113.53 | 24.13 | 14.23 | Upgrade
|
Depreciation & Amortization | 62.81 | 60.77 | 55.2 | 38.71 | 4.59 | 2.16 | Upgrade
|
Operating Expenses | 343.33 | 331.16 | 270.21 | 152.24 | 28.73 | 16.39 | Upgrade
|
Operating Income | 44.98 | 41.11 | 33.08 | 1.46 | -7.51 | -5.4 | Upgrade
|
Interest Expense | -35.37 | -33.6 | -25.29 | -9.01 | -1.94 | -1.45 | Upgrade
|
Interest & Investment Income | 0.81 | 0.76 | 0.65 | 0.56 | 0.45 | 0.24 | Upgrade
|
Net Interest Expenses | -34.56 | -32.84 | -24.64 | -8.45 | -1.48 | -1.2 | Upgrade
|
Income (Loss) On Equity Investments | -1.35 | -0.38 | -0.4 | -0.21 | -0.59 | - | Upgrade
|
Currency Exchange Gain (Loss) | 0.38 | 0.64 | -0.67 | -4.75 | -0.2 | - | Upgrade
|
Other Non Operating Income (Expenses) | -6.7 | -5.16 | -2 | 1.55 | 0.34 | 0.48 | Upgrade
|
EBT Excluding Unusual Items | 2.77 | 3.37 | 5.37 | -10.41 | -9.43 | -6.12 | Upgrade
|
Merger & Restructuring Charges | -10.12 | -6.59 | -2.49 | -9.99 | -3.22 | -0.69 | Upgrade
|
Gain (Loss) on Sale of Assets | 12.85 | 1.57 | 5.21 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | 56.52 | 42.56 | 0.28 | - | 6.91 | - | Upgrade
|
Other Unusual Items | -12.67 | -21.41 | 9.16 | -5.09 | -1.86 | -0.95 | Upgrade
|
Pretax Income | 49.35 | 19.5 | 17.53 | -25.49 | -7.61 | -7.76 | Upgrade
|
Income Tax Expense | 2.49 | 2.86 | -1.15 | 5.8 | -4.36 | 0.04 | Upgrade
|
Earnings From Continuing Operations | 46.86 | 16.64 | 18.68 | -31.29 | -3.25 | -7.79 | Upgrade
|
Net Income to Company | 46.86 | 16.64 | 18.68 | -31.29 | -3.25 | -7.79 | Upgrade
|
Minority Interest in Earnings | -17.34 | -16.56 | -17.31 | -12.89 | -0.48 | -0.02 | Upgrade
|
Net Income | 29.53 | 0.08 | 1.37 | -44.18 | -3.72 | -7.82 | Upgrade
|
Net Income to Common | 29.53 | 0.08 | 1.37 | -44.18 | -3.72 | -7.82 | Upgrade
|
Net Income Growth | - | -94.01% | - | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 239 | 237 | 221 | 191 | 134 | 97 | Upgrade
|
Shares Outstanding (Diluted) | 239 | 237 | 221 | 191 | 134 | 97 | Upgrade
|
Shares Change (YoY) | 5.77% | 7.18% | 15.61% | 42.56% | 38.17% | 45.75% | Upgrade
|
EPS (Basic) | 0.12 | 0.00 | 0.01 | -0.23 | -0.03 | -0.08 | Upgrade
|
EPS (Diluted) | 0.12 | 0.00 | 0.01 | -0.23 | -0.03 | -0.08 | Upgrade
|
EPS Growth | - | -94.42% | - | - | - | - | Upgrade
|
Free Cash Flow | 49.19 | 41.05 | 69.93 | -30.21 | -6.52 | -3.11 | Upgrade
|
Free Cash Flow Per Share | 0.21 | 0.17 | 0.32 | -0.16 | -0.05 | -0.03 | Upgrade
|
Gross Margin | 46.33% | 47.97% | 53.29% | 50.84% | 42.23% | 33.49% | Upgrade
|
Operating Margin | 5.37% | 5.30% | 5.81% | 0.48% | -14.95% | -16.45% | Upgrade
|
Profit Margin | 3.52% | 0.01% | 0.24% | -14.61% | -7.41% | -23.83% | Upgrade
|
Free Cash Flow Margin | 5.87% | 5.29% | 12.29% | -9.99% | -12.97% | -9.46% | Upgrade
|
EBITDA | 97.24 | 91.33 | 80.22 | 35.27 | -4.76 | -4.68 | Upgrade
|
EBITDA Margin | 11.60% | 11.77% | 14.09% | 11.67% | -9.48% | -14.26% | Upgrade
|
D&A For EBITDA | 52.26 | 50.22 | 47.13 | 33.81 | 2.75 | 0.72 | Upgrade
|
EBIT | 44.98 | 41.11 | 33.08 | 1.46 | -7.51 | -5.4 | Upgrade
|
EBIT Margin | 5.37% | 5.30% | 5.81% | 0.48% | -14.95% | -16.45% | Upgrade
|
Effective Tax Rate | 5.05% | 14.67% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template.